State MA
Clinical Trials in Massachusetts
Recruiting clinical trials with at least one study location in Massachusetts. Data updated daily from ClinicalTrials.gov.
Top Conditions in Massachusetts
Frequently Asked Questions — Clinical Trials in Massachusetts
How many clinical trials are currently recruiting in Massachusetts?
ClinicalMetric currently tracks 482 actively recruiting clinical trials with at least one location in Massachusetts. The total number of registered studies—including active but not currently enrolling trials—is 482. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Massachusetts?
Massachusetts hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Multiple Myeloma, Obesity, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Massachusetts serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Massachusetts?
To join a clinical trial in Massachusetts, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Massachusetts maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in Massachusetts
NCT04629586 N/A
Recruiting
The T1D Exchange Registry
Condition
Diabetes Mellitus, Type 1
Enrollment
50,000 pts
Location
United States
Sponsor
T1D Exchange, United States
NCT06395103 Phase 1, Phase 2
Recruiting
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants Wit...
Condition
B-cell Acute Lymphoblastic Leukemia
Enrollment
90 pts
Location
United States, Australia, Belgium
Sponsor
Merck Sharp & Dohme LLC
NCT06480383 Phase 2
Recruiting
Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiet...
Condition
Generalized Anxiety Disorder
Enrollment
705 pts
Location
United States, Bulgaria, Czechia
Sponsor
Intra-Cellular Therapies, Inc.
NCT05354622 N/A
Recruiting
Hereditary Spastic Paraplegia Genomic Sequencing Initiative (HSPseq)
Condition
Hereditary Spastic Paraplegia
Enrollment
200 pts
Location
United States
Sponsor
Boston Children's Hospital
NCT05264779 N/A
Recruiting
The Periviable GOALS Decision Support Tool
Condition
Pregnancy Preterm
Enrollment
300 pts
Location
United States
Sponsor
Indiana University
NCT07468188 N/A
Recruiting
Diabetes Body Project 2
Condition
Eating Disorders
Enrollment
42 pts
Location
United States
Sponsor
Joslin Diabetes Center
NCT05821959 Phase 1, Phase 2
Recruiting
Gene Therapy Trial for Otoferlin Gene-mediated Hearing Loss
Condition
Sensorineural Hearing Loss, Bilateral
Enrollment
22 pts
Location
United States, Canada, Taiwan
Sponsor
Akouos, Inc.
NCT06993610 Phase 2
Recruiting
Tibulizumab Skin Healing and Inflammation Evaluation for Lasting Defense
Condition
Hidradenitis Suppurativa (HS)
Enrollment
225 pts
Location
United States, Canada, Germany
Sponsor
Zura Bio Inc
NCT06701682 Phase 2
Recruiting
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort A: Vilob...
Condition
Acute Respiratory Distress Syndrome (ARDS)
Enrollment
200 pts
Location
United States
Sponsor
PPD Development, LP
NCT06786624 Phase 3
Recruiting
Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatmen...
Condition
Major Depressive Disorder
Enrollment
200 pts
Location
United States
Sponsor
Neurocrine Biosciences
NCT06333262 Phase 2
Recruiting
Fixed Duration Pirtobrutinib and Obinutuzumab in Chronic Lymphocytic Leukemia
Condition
Chronic Lymphocytic Leukemia
Enrollment
60 pts
Location
United States
Sponsor
Inhye Ahn
NCT07223203 Phase 3
Recruiting
TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients...
Condition
Hereditary Transthyretin-Mediated Amyloidosis With Polyneuropathy
Enrollment
125 pts
Location
United States, South Korea, Sweden
Sponsor
Alnylam Pharmaceuticals
NCT07219173 Phase 2
Recruiting
A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With...
Condition
Asthma
Enrollment
531 pts
Location
United States, Argentina, Brazil
Sponsor
Eli Lilly and Company
NCT02000089 Phase 3
Recruiting
The Cancer of the Pancreas Screening-5 CAPS5)Study
Condition
Pancreas Cancer
Enrollment
9,000 pts
Location
United States
Sponsor
Johns Hopkins University
NCT06926868 Phase 2, Phase 3
Recruiting
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Prev...
Condition
Breast Neoplasms
Enrollment
500 pts
Location
United States, Argentina, Australia
Sponsor
Bristol-Myers Squibb
NCT01998750 N/A
Recruiting
Study to Investigate Genetic Causes of Severe Early Childhood Onset Obesity.
Condition
Obesity
Enrollment
500 pts
Location
United States
Sponsor
Columbia University
NCT07473713 Phase 1
Recruiting
Veverimer to Decrease Net Acid Excretion and Bone Resorption in Adults With Oste...
Condition
Osteopenia
Enrollment
60 pts
Location
United States
Sponsor
Tufts Medical Center
NCT06009159 N/A
Recruiting
Vagus Nerve Stimulation(VNS) As Treatment For Fibromyalgia Patients
Condition
Fibromyalgia
Enrollment
60 pts
Location
United States
Sponsor
Massachusetts General Hospital
NCT04079179 Phase 2
Recruiting
Cobimetinib in Refractory Langerhans Cell Histiocytosis (LCH), and Other Histioc...
Condition
Langerhan's Cell Histiocytosis
Enrollment
90 pts
Location
United States
Sponsor
Carl Allen
NCT04647227 Phase 4
Recruiting
SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors
Condition
Hemophilia A With Inhibitor
Enrollment
55 pts
Location
United States
Sponsor
American Thrombosis and Hemost
NCT07142356 Phase 2
Recruiting
A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension
Condition
Uncontrolled Hypertension
Enrollment
280 pts
Location
United States
Sponsor
Retension Pharmaceuticals. Inc
NCT05096481 Phase 2
Recruiting
PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and...
Condition
High Grade Glioma
Enrollment
120 pts
Location
United States
Sponsor
Nationwide Children's Hospital
NCT05303519 Phase 3
Recruiting
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
Condition
Glioma
Enrollment
365 pts
Location
United States, Australia, China
Sponsor
Nuvation Bio Inc.
NCT07357428 N/A
Recruiting
Connect-One: Early Feasibility Study of Connexus® Brain-Computer Interface (BCI)
Condition
Amyotrophic Lateral Sclerosis
Enrollment
2 pts
Location
United States
Sponsor
Paradromics
NCT05920356 Phase 3
Recruiting
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab P...
Condition
Non-Small Cell Lung Cancer (NSCLC)
Enrollment
750 pts
Location
United States, Argentina, Australia
Sponsor
Amgen
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology